Concepedia

Author

Brian VanScoy

Institute for Clinical Pharmacodynamics (United States)ORCID

Also Known As

B. D. VanScoy, B. VanScoy, Brian D VanScoy, Brian D. VanScoy, Brian VanScoy, Brian Vanscoy

59

Publications

1.3K

Citations

21

H-Index

39

Concepts

All Affiliations

Institute for Clinical Pharmacodynamics (United States)Albany Research InstituteUniversity of OxfordJMI LaboratoriesUnited States Army Medical Research Institute of Infectious Diseases
BV

About

Brian VanScoy is an author at Institute for Clinical Pharmacodynamics (United States) specializing in antimicrobial resistance, medicine, and clinical microbiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

14

563

2

Microbiology

13

13

521

3

Health Sciences

11

11

467

4

Immunology

2

2

114

5

Cell Biology

1

1

42

Brian VanScoy

×

30

Publications

1.2K

Citations

20

H-Index

YearCitations

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an <i>In Vitro</i> Infection Model

Brian VanScoy, Rodrigo E. Mendes, Anthony M. Nicasio,

Antimicrobial Agents and Chemotherapy

2013

105

<i>In Vivo</i> Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa

Alexander J. Lepak, Miao Zhao, Brian VanScoy,

Antimicrobial Agents and Chemotherapy

2017

101

Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases

Arnold Louie, Mariana Castanheira, Weiguo Liu,

Antimicrobial Agents and Chemotherapy

2011

73

Saturability of Granulocyte Kill of Pseudomonas aeruginosa in a Murine Model of Pneumonia

George L. Drusano, Brian VanScoy, W. Liu,

Antimicrobial Agents and Chemotherapy

2011

72

Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane

Brian VanScoy, Rodrigo E. Mendes, Jennifer McCauley,

Antimicrobial Agents and Chemotherapy

2013

67

<i>In Vivo</i> Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model

Miao Zhao, Alexander J. Lepak, Brian VanScoy,

Antimicrobial Agents and Chemotherapy

2018

66

Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing Design

Alexander J. Lepak, Miao Zhao, Brian VanScoy,

Antimicrobial Agents and Chemotherapy

2017

61

Resistance Emergence Mechanism and Mechanism of Resistance Suppression by Tobramycin for Cefepime for Pseudomonas aeruginosa

George L. Drusano, Robert A. Bonomo, Nadzeya Bahniuk,

Antimicrobial Agents and Chemotherapy

2011

57

Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an <i>In Vitro</i> Infection Model

Brian VanScoy, Jennifer McCauley, Evelyn J. Ellis‐Grosse,

Antimicrobial Agents and Chemotherapy

2015

56

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an <i>In Vitro</i> Infection Model

Anthony M. Nicasio, Brian VanScoy, Rodrigo E. Mendes,

Antimicrobial Agents and Chemotherapy

2016

54

Page 1